Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Kiromic Biopharma Inc (KRBP)

OTC Markets
Currency in USD
Disclaimer
1.150
0.000(0.00%)
Closed
KRBP Scorecard
Full Analysis
Operates with a significant debt burden
Fair Value
Day's Range
1.1501.150
52 wk Range
0.1803.780
Prev. Close
1.15
Open
1.15
Day's Range
1.15-1.15
52 wk Range
0.18-3.78
Volume
506
Average Volume (3m)
3,040
1-Year Change
531.87%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
KRBP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Kiromic Biopharma Inc Company Profile

Kiromic BioPharma, Inc., a clinical stage biotherapeutics company, utilizes engineered and non-engineered Gamma Delta T cell (GDT) technologies to develop therapies for solid tumors. The company develops Deltacel-01, which is in Phase 1 clinical trial, for patients with non-small cell lung cancer; Isocel in combination with low-dose radiation to treat Mesothelin Isoform 2 positive solid malignancies; ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; Procel in combination with low-dose radiation to treat PD-L1 positive solid malignancies; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1. It has a license agreement with Longwood University; and a research and development collaboration agreement with Molipharma, S.R.L. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

Compare KRBP to Peers and Sector

Metrics to compare
KRBP
Peers
Sector
Relationship
P/E Ratio
−0.1x−2.7x−0.6x
PEG Ratio
0.000.010.00
Price/Book
−0.3x0.9x2.6x
Price / LTM Sales
-22.2x3.2x
Upside (Analyst Target)
-216.2%44.2%
Fair Value Upside
Unlock9.0%7.9%Unlock

FAQ

What Is the Kiromic (KRBP) Stock Price Today?

The Kiromic stock price today is 1.15

What Stock Exchange Does Kiromic Trade On?

Kiromic is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Kiromic?

The stock symbol for Kiromic is "KRBP."

What Is the Kiromic Market Cap?

As of today, Kiromic market cap is 1.78M.

What is Kiromic Earnings Per Share?

The Kiromic EPS is -19.89.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.